Genetron Statistics
Share Statistics
Genetron has 31.62M
shares outstanding. The number of shares has increased by 0%
in one year.
| Shares Outstanding | 31.62M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 10,352 |
| FTD / Avg. Volume | 19.96% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -2.43 and the forward
PE ratio is null.
Genetron's PEG ratio is
-0.02.
| PE Ratio | -2.43 |
| Forward PE | n/a |
| PS Ratio | 3.3 |
| Forward PS | n/a |
| PB Ratio | 3.94 |
| P/FCF Ratio | -3.97 |
| PEG Ratio | -0.02 |
Financial Ratio HistoryEnterprise Valuation
Genetron has an Enterprise Value (EV) of 2.13B.
| EV / Sales | 3.28 |
| EV / EBITDA | -3.27 |
| EV / EBIT | -4.63 |
| EV / FCF | -3.93 |
Financial Position
The company has a current ratio of 1.82,
with a Debt / Equity ratio of 0.29.
| Current Ratio | 1.82 |
| Quick Ratio | 1.71 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | -0.24 |
| Debt / FCF | -0.29 |
| Interest Coverage | -5.67 |
Financial Efficiency
Return on Equity is -161.85% and Return on Invested Capital is -97.73%.
| Return on Equity | -161.85% |
| Return on Assets | -90.62% |
| Return on Invested Capital | -97.73% |
| Revenue Per Employee | $655,293.05 |
| Profits Per Employee | $-890,119.84 |
| Employee Count | 993 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 8.7 |
Taxes
| Income Tax | 73.26M |
| Effective Tax Rate | -9.04% |
Stock Price Statistics
The stock price has increased by 0% in the
last 52 weeks. The beta is 0.5, so Genetron's
price volatility has been higher than the market average.
| Beta | 0.5 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 3.87 |
| 200-Day Moving Average | 3.31 |
| Relative Strength Index (RSI) | 70.57 |
| Average Volume (20 Days) | 51,864 |
Income Statement
In the last 12 months, Genetron had revenue of 650.71M
and earned -883.89M
in profits. Earnings per share was -9.53.
| Revenue | 650.71M |
| Gross Profit | 281.43M |
| Operating Income | -631.62M |
| Net Income | -883.89M |
| EBITDA | -651.24M |
| EBIT | -699.14M |
| Earnings Per Share (EPS) | -9.53 |
Full Income StatementBalance Sheet
The company has 176.27M in cash and 158.57M in
debt, giving a net cash position of 17.7M.
| Cash & Cash Equivalents | 176.27M |
| Total Debt | 158.57M |
| Net Cash | 17.7M |
| Retained Earnings | -6.25B |
| Total Assets | 975.33M |
| Working Capital | 319.08M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -460.2M
and capital expenditures -82.14M, giving a free cash flow of -542.34M.
| Operating Cash Flow | -460.2M |
| Capital Expenditures | -82.14M |
| Free Cash Flow | -542.34M |
| FCF Per Share | -5.84 |
Full Cash Flow StatementMargins
Gross margin is 43.25%, with operating and profit margins of -97.07% and -135.84%.
| Gross Margin | 43.25% |
| Operating Margin | -97.07% |
| Pretax Margin | -124.58% |
| Profit Margin | -135.84% |
| EBITDA Margin | -100.08% |
| EBIT Margin | -97.07% |
| FCF Margin | -83.35% |
